Put Options

19 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$78.93 - $95.84 $39,465 - $47,920
-500 Reduced 33.33%
1,000 $89,000
Q2 2024

Aug 14, 2024

SELL
$65.72 - $80.5 $46,004 - $56,350
-700 Reduced 31.82%
1,500 $120,000
Q1 2024

May 15, 2024

SELL
$69.39 - $97.64 $83,268 - $117,168
-1,200 Reduced 35.29%
2,200 $175,000
Q4 2023

Feb 14, 2024

SELL
$57.42 - $83.61 $160,776 - $234,108
-2,800 Reduced 45.16%
3,400 $270,000
Q3 2023

Nov 14, 2023

BUY
$69.25 - $82.21 $138,500 - $164,420
2,000 Added 47.62%
6,200 $433,000
Q2 2023

Aug 14, 2023

BUY
$58.41 - $90.35 $110,979 - $171,665
1,900 Added 82.61%
4,200 $301,000
Q1 2023

May 15, 2023

SELL
$58.39 - $75.0 $724,036 - $930,000
-12,400 Reduced 84.35%
2,300 $141,000
Q4 2022

Feb 14, 2023

BUY
$39.94 - $79.72 $551,172 - $1.1 Million
13,800 Added 1533.33%
14,700 $1.13 Million
Q3 2022

Nov 14, 2022

SELL
$36.06 - $69.85 $32,454 - $62,864
-900 Reduced 50.0%
900 $40,000
Q2 2022

Aug 08, 2022

BUY
$21.74 - $46.75 $26,087 - $56,100
1,200 Added 200.0%
1,800 $69,000
Q1 2022

May 16, 2022

BUY
$23.7 - $41.39 $2,370 - $4,139
100 Added 20.0%
600 $25,000
Q4 2021

Feb 14, 2022

SELL
$30.7 - $43.36 $46,050 - $65,040
-1,500 Reduced 75.0%
500 $19,000
Q3 2021

Nov 15, 2021

SELL
$19.91 - $68.26 $111,496 - $382,256
-5,600 Reduced 73.68%
2,000 $66,000
Q2 2021

Aug 16, 2021

BUY
$50.63 - $73.5 $248,087 - $360,150
4,900 Added 181.48%
7,600 $513,000
Q1 2021

May 17, 2021

SELL
$55.91 - $81.44 $329,869 - $480,496
-5,900 Reduced 68.6%
2,700 $153,000
Q4 2020

Feb 16, 2021

BUY
$66.31 - $86.52 $232,085 - $302,820
3,500 Added 68.63%
8,600 $701,000
Q3 2020

Nov 16, 2020

SELL
$68.34 - $85.84 $300,696 - $377,696
-4,400 Reduced 46.32%
5,100 $363,000
Q2 2020

Aug 14, 2020

BUY
$49.87 - $98.69 $468,778 - $927,686
9,400 Added 9400.0%
9,500 $782,000
Q4 2019

Feb 14, 2020

BUY
$16.71 - $106.24 $1,671 - $10,624
100 New
100 $10,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.73B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.